European Network of AI Excellence Centres (ELISE) 1st open call
8 August 2022
Efstratios Gavves
Ellogon.AI’s co-founder Efstratios Gavves has been interviewed by the European Network of AI Excellence Centres (ELISE) as the company was part of ELISE 1st Open Call.
Read the interview: https://www.elise-ai.eu/events/using-artificial-intelligence-to-select-the-right-cancer-patients-for-immunotherapy
Read more
KWF grant together with Amsterdam UMC, NKI and UvA
12 January 2023KWF grant together with Amsterdam UMC, NKI and UvA 12 January 2023 Jessica We are happy to announce that Ellogon.AI has received a KWF grant together with the Amsterdam UMC,…
EIDOS runs on UbiOps
29 December 2022EIDOS runs on UbiOps 29 December 2022 Jessica Hot off the press! Working with the Netherlands Cancer Institute, Ellogon.AI has developed a faster and more efficient method of…
WeakSTIL: Weak whole-slide image level stromal tumor infiltrating lymphocyte scores are all you need
4 April 2022Scientific publication by Yoni Schirris, PhD student of the HISTO-AI project.